Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Rajavelu Esther. Insider active across 1 company, notably Spero Therapeutics, Inc.. Cumulatively, 8 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €185k. History available since 13 November 2023. The latest transaction was disclosed on 6 February 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Rajavelu Esther is a declarant linked to Spero Therapeutics, Inc. (XNAS), with the role listed as See Remarks. There are 8 filings in total, and across the 8 sampled filings, the recorded transactions run from 2023-11-15 to 2026-02-09, with 0 in buys and 185480 in sells, and the modal transaction nature is Attribution.